Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety and Efficacy of Lacosamide in Postherpetic Neuralgia
NCT00238511Phase 2Completed
- Sponsor
- UCB
- Start
- Nov 2002
- Primary completion
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lacosamide in postherpetic neuralgia (PHN), sponsored by UCB. Started Nov 2002; status: completed.
02
Drugs
lacosamide
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00238511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238511.